These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25566917)

  • 21. Fox-Fordyce disease: response to adapalene 0.1%.
    Kassuga LE; Medrado MM; Chevrand NS; Salles Sde A; Vilar EG
    An Bras Dermatol; 2012; 87(2):329-31. PubMed ID: 22570049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris.
    Del Rosso JQ; Schmidt NF
    Cutis; 2010 Jan; 85(1):15-24. PubMed ID: 20184207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fox Fordyce disease--views on pathogenesis].
    Leyh F
    Hautarzt; 1973 Nov; 24(11):482-5. PubMed ID: 4777528
    [No Abstract]   [Full Text] [Related]  

  • 24. Dissecting cellulitis: responding to topical steroid and oral clindamycin.
    Garelli V; Didona D; Paolino G; Didona B; Calvieri S; Rossi A
    G Ital Dermatol Venereol; 2017 Jun; 152(3):324-325. PubMed ID: 28409586
    [No Abstract]   [Full Text] [Related]  

  • 25. Topical treatment for the inflamed lesion in acne, rosacea, and pseudofolliculitis barbae.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):4-5. PubMed ID: 15228127
    [No Abstract]   [Full Text] [Related]  

  • 26. Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea.
    Breneman D; Savin R; VandePol C; Vamvakias G; Levy S; Leyden J
    Int J Dermatol; 2004 May; 43(5):381-7. PubMed ID: 15117375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris.
    Khodaeiani E; Fouladi RF; Amirnia M; Saeidi M; Karimi ER
    Int J Dermatol; 2013 Aug; 52(8):999-1004. PubMed ID: 23786503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.
    Chassard D; Kanis R; Namour F; Evene E; Ntssikoussalabongui B; Schmitz V
    J Dermatolog Treat; 2006; 17(3):154-7. PubMed ID: 16854755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
    Kellett N; West F; Finlay AY
    Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
    Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid remission with calcipotriol betamethasone in refractory Fox-Fordyce disease.
    Yang L; Zhang S; Wang T; He Z; Liu Y; Zdravković TP
    Dermatol Ther; 2020 Mar; 33(2):e13223. PubMed ID: 31917488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
    Bikowski J; Callender VD; Del Rosso JQ; Draelos ZD; Tanghetti E
    Cutis; 2006 Aug; 78(2 Suppl 1):13-20. PubMed ID: 17966495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of pruritus with botulinum toxin in a pediatric patient with Fox-Fordyce disease.
    Klager S; Kumar MG
    Pediatr Dermatol; 2021 Jul; 38(4):950-951. PubMed ID: 34060125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris.
    Tschen EH; Katz HI; Jones TM; Monroe EW; Kraus SJ; Connolly MA; Levy SF
    Cutis; 2001 Feb; 67(2):165-9. PubMed ID: 11236229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study.
    Jarratt MT; Brundage T
    J Drugs Dermatol; 2012 Mar; 11(3):318-26. PubMed ID: 22395582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris.
    Alirezaï M; Gerlach B; Horvath A; Forsea D; Briantais P; Guyomar M
    Eur J Dermatol; 2005; 15(4):274-8. PubMed ID: 16048758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Perifollicular xanthomatosis as a key histological finding in Fox-Fordyce disease].
    Mataix J; Silvestre JF; Niveiro M; Lucas A; Pérez-Crespo M
    Actas Dermosifiliogr; 2008 Mar; 99(2):145-8. PubMed ID: 18346437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%.
    Zhang JZ; Li LF; Tu YT; Zheng J
    J Dermatolog Treat; 2004 Dec; 15(6):372-8. PubMed ID: 15764049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes.
    Leyden JJ
    Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How patients experience and manage dryness and irritation from acne treatment.
    Feldman SR; Chen DM
    J Drugs Dermatol; 2011 Jun; 10(6):605-8. PubMed ID: 21637901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.